Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Lamotrigine for Prevention of Depressive Recurrence in Bipolar Disorder
NCT01864551Phase 4Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Aug 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of olanzapine in bipolar disorder (BD) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Time period to the recurrence of depressive episode at 12 months. Started Aug 2008; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01864551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864551.